AIM ImmunoTech Inc (AIM)
NYSE MKT:AIM
Holding AIM?
Track your performance easily

AIM ImmunoTech (AIM) Financial Statements

839 Followers

AIM ImmunoTech Financial Overview

AIM ImmunoTech's market cap is currently ―. The company's EPS TTM is $-0.569; its P/E ratio is -0.52; AIM ImmunoTech is scheduled to report earnings on November 15, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 50.00K$ 46.00K$ 42.00K$ 49.00K$ 57.00K
Gross Profit$ 42.00K$ 16.00K$ 42.00K$ 49.00K$ 203.00K
EBIT$ -1.66M$ -8.16M$ -5.24M$ 4.77M$ -5.00M
EBITDA$ -1.40M$ -8.10M$ -5.16M$ 4.82M$ -4.83M
Net Income Common Stockholders$ -1.84M$ -7.82M$ -4.91M$ 5.03M$ -4.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.06M$ 22.43M$ 28.40M$ 30.85M$ 34.19M
Total Assets$ 15.71M$ 27.86M$ 33.62M$ 37.31M$ 40.49M
Total Debt$ 3.36M$ 750.00K$ 803.00K$ 814.00K$ 837.00K
Net Debt$ -6.70M$ -21.68M$ -27.59M$ -30.04M$ -33.35M
Total Liabilities$ 9.61M$ 5.26M$ 3.48M$ 2.47M$ 2.02M
Stockholders Equity$ 6.10M$ 22.60M$ 30.14M$ 34.99M$ 38.47M
Cash Flow-
Free Cash Flow$ -3.29M$ -6.05M$ -2.21M$ -3.63M$ -2.64M
Operating Cash Flow$ -3.01M$ -5.67M$ -2.16M$ -3.66M$ -6.07M
Investing Cash Flow$ 826.00K$ -336.00K$ -204.00K$ -78.00K$ 3.36M
Financing Cash Flow$ 2.44M$ 233.00K$ 5.00K$ 100.00K-
Currency in USD

AIM ImmunoTech Earnings and Revenue History

AIM ImmunoTech Debt to Assets

AIM ImmunoTech Cash Flow

AIM ImmunoTech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis